Replies to post #90 on Vital Therapies, Inc. (VTL)

[joezapp]

We now agree all-around. There is a lot of risk with VTL, and at some point the risk/reward could become too much. But with the FDA giving VTL the opportunity to succeed due to the need, and with an insider putting up over $400,000 of his own money at over $9/share, the risk/reward profile remains good under $12 for a long. Of course, this is a spec stock and requires risk capital.